Are you a person living with arthritis? Do you want to learn more about biosimilars and the transition policies being implemented across Canada? Join Arthritis Research Canada/Arthrite-recherche Canada’s Scientific Director, Dr. Diane Lacaille, for an informative and interactive free webinar.
Biosimilars are alternatives to original brand biologic medications used in the treatment of certain types of arthritis that are as safe and effective as the originals. While biologics have provided major advances to the treatment of arthritis, they come at a significant cost. Biologics have become the most expensive drug class in provincial health care budgets.
As patents for original brand biologic medicines expire other manufacturers can produce a similar version of the medication at a lower cost. Biosimilars provide opportunities for more sustainable health care budgets and for funding new drugs coming into the market. Health Canada authorizes biosimilars for sale using rigorous regulatory standards. Studies need to show that biosimilars have the same effectiveness and safety as the original drugs.
Please sign-up for our webinar to learn more about this important topic!
Length: 1 hour, including Q&A.